Skip to content

US Dept of Defense – Parkinson’s Research Program

Home / Funding Opportunity / US Dept of Defense – Parkinson’s Research Program

US Dept of Defense – Parkinson’s Research Program

twitterlinkedin

Early Investigator Research Award HT9425-23-PRP-EIRA

  • up to USD$500,000 over 2 years
  • letters of intent due 27 July 2023
  • postdoctoral, clinical fellows, assistant professors within 10 years of PhD or residency training
  • Supports research opportunities for investigators in the early stages of their careers, under the guidance of one or two designated Mentor(s).
  • Mentor(s) must have experience in Parkinson’s Disease research and mentoring
  • must address at least one of the FY23 Focus Areas
  • preliminary data encouraged but not required
  • clinical trials not allowed


Investigator-Initiated Research Award 
HT9425-23-PRP-IIRA

  • up to USD$1.5M over 3 years
  • letters of intent due 27 July 2023
  • Supports highly rigorous, multidisciplinary, high- impact research projects that have the potential to make an important contribution to Parkinson’s research.
  • supports the full spectrum of research from basic science through clinical research.
  • must address at least one of the FY23 Focus Areas.
  • Preliminary data to support feasibility encouraged but not required
  • clinical trials allowed


Synergistic Idea Award
HT9425-23-PRP-SIA

  • up to USD$3M over 4 years
  • letters of intent due 27 July 2023
  • Supports new ideas that represent synergistic approaches to PD research involving two or four PIs.
  • Investigators should utilize their complementary and synergistic perspectives to address a central problem or question in Parkinson’s research.
  • designed to support both new and pre-existing partnerships and encourages participation of PIs from other research fields.
  • must address at least one of the FY23 Focus Areas.
  • Preliminary data to support feasibility encouraged but not required.
  • clinical trials allowed


23FY Focus Areas

  • Biological mechanisms or biomarkers, including biologically informed clinical evaluations, of non-motor symptoms that could lead to the development of treatments for PD. Applications focused on laboratory models through to human subjects, including computational approaches, would be considered. Examples of non-motor symptoms of interest include, but are not limited to:
    • Cognitive dysfunction relevant to PD
    • Psychiatric dysfunction
    • Sleep and circadian rhythms disruptions
    • Autonomic dysfunction
    • Sensory dysfunction
    • Other non-motor symptoms including fatigue, apathy, and impulse control disorders
  • Biological mechanisms or biomarkers associated with non-pharmacological interventions for PD. Examples of non-pharmacological interventions of interest include:
    • Exercise
    • Diet
    • Neuro-stimulation therapy
    • Neurosurgical


Supporting documents for download

Read more

You may be also interested in ...